The MOR Code - 2026 July
The MOR Code
The MOR Code
A letter from Michelle.
Welcome to The MOR Code.
In April of 2021, I took naltrexone before drinking.
I did not know it then, but that one decision would change my understanding of addiction, identity, design, and what it means to thrive.
Over the course of that first year, something I had believed I would carry for the rest of my life began to loosen. The grip gradually disappeared. Not through willpower. Not through white-knuckling. Not through becoming a “better” or more disciplined person.
Instead, I began to understand that something profound was happening in the body and brain. At the very moment alcohol expected to deliver its reward, naltrexone was occupying the receptor. Over time, the reward loop began to unlearn itself.
I walked out the other side of with a working reward system — and with a question that has not left me since:
What happened in the body and brain that allowed a craving, a desire, and even an identity to be unlearned? And how do we help more people find that path?
That question became the foundation for my work.
It became MOR Studio, an architecture practice built around spaces that support the biology of thriving. It became My Dopamine Blueprint™. It became my forthcoming book, MOR: The Design of Our Addictions — How the Mu-Opioid Receptor Shapes Our Desires, Our Bodies, and Our Futures — and How to Take Back the Blueprint.
And now, it becomes this newsletter.
The MOR Code is where I bring the science out of the journals and into the room with you — into the spaces you inhabit, the routines you repeat, the choices you make, and the reward systems quietly shaping your life.
This work is personal, but it is also much bigger than me.
For too long, we have treated addiction, behavior, and many of the health outcomes that follow as failures of character. I believe we are looking at something deeper: receptor systems, reward loops, environments, and patterns that can be understood — and designed around.
That is the moonshot behind this work: to help change the way we understand addiction, craving, reward, and recovery.
Not as moral failure.
Not as a life sentence.
But as designable biology.
This is Issue 01 of The MOR Code.
I am so glad you are here.
We have only just begun.
Michelle Opal Rutkowski, AIAFounder, MOR Studio · Founder, My Dopamine Blueprint™
Your Dopamine Blueprint.
The loop that runs your behavior. Four nodes. One circuit. Understanding it is the beginning of taking it back.
or felt in your biology
that pulls you forward
landing on MOR
cues to filter for next
“Knowing where the biological molecules of motivation come from can make motivation much less of a mystery.”
— Michelle Opal Rutkowski, AIA
Author of MOR: The Design of Our Addictions
How we change the loop's call.
The practice is a three-step ladder — Render, Clean Your Filter, Inject CDMR. Each step works on the same receptor system the research is describing, and each one prepares the next.
- 01 Render. Picture the life that pulls you forward, in vivid sensory detail, and let gratitude land while you are picturing it. This is a vision board for your reward loop — endorphins fire on the future, and the body begins filtering for the cues that meet it.
- 02 Clean your filter. Start listening to your compass and stop feeding the system negative data. Clean up your social media, your inputs, and the dialog between you and you — and between you and your environment — so the filter stays clear enough to catch the cues Step One taught it to look for.
- 03 Inject CDMR. Place Connection, Discovery, Movement, and Rest into the exact rooms, routines, and relationships where you want to build motivation. This is where the four pillars stop being an idea and start becoming the architecture of your day.
Render.
In architecture, the render is the first step of the project. It is the first time the architect envisions how the occupant will feel experiencing the site, the building, the space — the first time that feeling is shown in vivid detail and color. The render sets the tone of where a project is headed.
Think of it as a vision board for your reward loop. The reward loop is rendered in endorphins — the signal that says this, more of this. When you render the life you want in real sensory detail, and let gratitude land while you are picturing it, the endorphins fire now, on the future. Your body begins filtering for the cues that meet that goal. The render is not hope; it is pre-learning. It is telling the receptor system where you are going so the reticular activating system knows what to notice on the way.
Render how your perfect day would feel. Then begin to accept it, in gratitude, as if it were already here.
Clean your filter.
Step one taught your body what to look for. Step two makes sure it can still see. The filter is the reticular activating system — the part of the brain that decides which signals are worth your attention and which get dropped. It is porous by design, and everything you feed it becomes what you notice.
Start listening to your compass. Stop putting negative data into the system. Clean up your social media, your feeds, your notifications, the voices around your table — every controllable input to your day. Watch the dialog between you and you, and the dialog between you and your environment; both count as inputs. When the filter is loud with static, the endorphin cues your render is asking for slide past unregistered. When the filter is clean, the cues land, and the reward loop starts closing on the life you rendered instead of the one the algorithm did.
Pick one input today — one feed, one thread, one conversation loop — that is putting negative data into your system, and quiet it. Then notice what your compass says once the static is gone.
Place the four pillars where you want to build motivation.
Endorphins land across the full breadth of connection — to a face that meets yours, to art that stops you mid-room, to music that arrives in the chest, to nature, to sunlight on skin, to worship, to God, to purpose larger than yourself, to meaning that holds the day. The mu-opioid receptor is what makes any of it register as warmth instead of data. Connection is the widest of the four pillars — every channel by which a human is held by something other than themselves.
Endorphins land when a human learns, creates, completes, or arrives — the finished sketch, the line that finally reads, the pattern that resolves, the model that clicks, the "aha." The mu-opioid receptor is what makes the arrival register as worth the effort. Discovery is where endorphins come home when something new is made or understood.
Endorphins are part of what carries a human from stillness into pursuit — a creation, a destination, a purpose. Movement is the temporary spike that lifts the body into the reach toward what you want to make or where you want to go. The mu-opioid receptor is one of several signals here, alongside others that keep the body in motion.
Endorphins renew when a human chooses an intentional reset — meditation, breath, a dark room, a fast from a familiar signal, the chosen pause. The mu-opioid receptor is the receptor of "enough," and like every receptor it loses sensitivity to a signal that never stops. Rest is how signal strength comes back — the chosen practice of clearing the channel so the next dose can land.
Walk it. Don't pace it.
Walking and pacing is good for the body and mind. The bilateral movement, and access to blue sky, feeds your CDMR inputs — Connection, Discovery, Movement, and Rest — all at once.
The built environment shapes biology.
Six current peer-reviewed studies connected to the four CDMR pillars. Read in any order. The pillar bar at the top of each tile shows the reward-system filter at work.
The first study to read architecture from brain to heart — in the same subject, at the same time.
Nine façade configurations. Twenty subjects. Two instruments running at once. fNIRS reading blood-oxygen flow at the back of the brain. HRV reading the millisecond-level variation between heartbeats. Different façades pulled different brain–body responses; the data is reproducible. We are out of the territory where neuroarchitecture is a hypothesis. The instruments are listening.
Eight to nine minutes of nature reorganized the brain. Wetlands worked fastest.
EEG mapping across three urban green-space types: park, remnant forest, wetland. Within nine minutes, alpha was up and beta/gamma were down across all three. Wetlands delivered the most rapid stress recovery; manicured urban park was meaningfully behind. Nature works on the brain like a tuning fork — but only some natures hum at the right frequency.
The wall held the body in rest mode while the mind worked.
Living-wall exposure during cognitively demanding tasks significantly raised parasympathetic tone — measured as HF-HRV, the high-frequency band of heart rate variability that tracks the rest-and-restore branch. The shift happened during the mental effort, not after. The wall is no longer ornament; it is nervous-system infrastructure.
A walkable neighborhood causally produced more walking. Twins proved it.
A twin study tracking 7,400 individuals over eleven years found that for every 1% increase in neighborhood walkability, residents walked 0.42% more. A 55% walkability increase translated to nineteen extra minutes of walking per week — controlled for genetics, controlled for selection. The street grid, not the mood, was making the move.
Architecture is now in the brain-growth literature.
The hippocampus — the seahorse-shaped structure deep in the temporal lobe that runs memory and spatial navigation — keeps growing neurons throughout life. A new review formally entered architecture into that conversation, alongside exercise and novel environments, as a continuous input to adult neuron growth. Spatial complexity, daylight, and walkable variety are now inputs the field is naming.
Shaded vegetated areas were 12.7°C cooler in summer and 1.3°C warmer in winter.
The thermal envelope of a shaded outdoor space is its own microclimate. In peak summer the difference was 12.7°C; in winter, the same canopy held 1.3°C of warmth. Cognition, parasympathetic tone, and willingness to be outside at all track that envelope. Shade is not a luxury detail. It is the difference between a person walking and a person staying inside.
Michelle Opal Rutkowski, AIA · Founder, MOR Studio & My Dopamine Blueprint™North Scottsdale studio · portrait by A. Marie
What Naltrexone Did for Me
Fuels This Mission.
Naltrexone is the molecule that rewired my reward system from scratch — full-dose, an hour before drinking, through the Sinclair Method. The mu-opioid receptor was occupied during the exact moments alcohol would normally reward the brain, and the reward loop quietly extinguished itself over months. I walked out the other side with a working reward system and a question that hasn't left: what else is this 42-year-old, off-patent, sub-dollar-a-day molecule doing that no one is naming?
Of Americans with alcohol use disorder who were prescribed any medication for it in 2019 (AAFP, 2024). I was not one of them — I had to find naltrexone outside of my primary care.
Why a molecule this useful stays this quiet.
-
01
The FDA still labels it as a once-daily pill.
The Sinclair Method — naltrexone an hour before drinking, so the receptor is occupied only during the reward window — has decades of evidence behind it. The label hasn't caught up. Prescribers default to what the label says.
-
02
Stigma keeps it out of the room.
Alcohol use disorder is still framed as a character problem rather than a receptor problem, so the conversation rarely reaches a prescription pad. If 1.6% of people with AUD are offered a medication, the other 98.4% are being handed a diagnosis without a tool.
-
03
No one owns the molecule.
Naltrexone is 42 years old and off-patent. There is no industry sponsor to educate physicians, fund trials, or carry it into guidelines, so it lives on the edges of practice.
-
04
The research is spread across specialties that rarely read each other.
The mu-opioid receptor shows up throughout the body, so meaningful naltrexone signal is emerging in different clinical fields at once — without a central place putting the picture together.
That last one is why My Dopamine Blueprint™ exists — to be the synthesizer and umbrella. A single place where the science gets pulled together and the roadblocks get named out loud.
Two changes. Named out loud.
Take another look at the Sinclair Method.
Ask the FDA to update the label so the science catches up: targeted, pre-drinking dosing is where the evidence for alcohol use disorder sits — not the once-daily version prescribers default to.
Provide Sinclair in primary care.
The front door where alcohol use is actually noticed — not a downstream specialty referral.
A portion of every dollar My Dopamine Blueprint™ earns funds independent research on this generic molecule — the work the industry has no incentive to do. Expect this body of work to multiply across the next decade as the field catches up to the receptor.
42 years old · Off-patent · Sub-dollar-a-day · Just getting startedNaltrexone — full dose for the Sinclair Method, or low dose (LDN) for off-label use — is a prescription medication. The directories below are the most internationally routable starting points I have found for connecting with a naltrexone-literate clinician who can walk this with you. They are free to use. The MOR Code is education, not prescription — Michelle is a licensed architect and a neuroscience researcher, not a physician — and these are the doors I would point a friend to first.
International prescriber directory for low-dose naltrexone (LDN).
TSM provider locator for full-dose naltrexone via the Sinclair Method.
Naltrexone quieted neuroinflammation — and the anxiety and depression that came with it.
In alcohol-exposed mice, naltrexone reduced microglial activation — the brain's resident immune cells shifting out of their inflammatory state and back toward a calm, surveilling one. The behavioral data tracked: anxiety and depression-like behaviors dropped alongside the inflammation. The signal underneath: naltrexone's reach extends well past receptor blockade into glial regulation. The same molecule, a wider hand.
The first registered LDN-for-depression trial reported null. The trial design is the story.
A randomized, double-blind, placebo-controlled trial of LDN added on top of existing antidepressant treatment in moderate major depressive disorder. n = 37. 12 weeks. Up to 4.5 mg/day. MADRS dropped 10.5 on LDN, 9.8 on placebo, p = 0.97. Flat. Reported honestly, the headline is: adjunctive LDN did not alter depressive symptoms in moderate MDD.
Read for mechanism, the trial design is its own finding. The window may be inside the rebound, not past it. The population was wrong for the hypothesis — moderate MDD on a working antidepressant is not the neuroinflammatory, reward-deficit substrate LDN theory predicts will respond. The pill creates the capacity. The life provides the ligands. This study tested the pill.
LDN for Long COVID: the most consistent off-label signal in the literature.
An Irish case series and a 2025 meta-analysis continue to show LDN improving fatigue, brain fog, and post-exertional malaise in long COVID — the same fingerprint the NIH RECOVER program is now testing in a pivotal trial. Brief receptor blockade. Endogenous opioid rebound. Glial calming. Three mechanisms, one molecule — and the cleanest off-label signal in the literature is still landing in a population that maps closely to the neuroinflammatory, reward-deficit substrate LDN theory predicts will respond.
Open Mic
Reader Questions
Your turn to ask.
Reply to this letter with a question or a comment, and Michelle may address or highlight it in next month's issue.
If this issue moved you, send it to one person.
The MOR Code grows by word of mouth. If a paragraph in here changed the way you looked at your own reward system — or someone you love — forward this letter to them. That is how this work travels.
Forward this issue.
Send it to one friend, one family member, or one clinician who should be reading the MOR literature. One is enough.
Add your name to the list.
New readers can subscribe at mydopamineblueprint.com to receive The MOR Code on the 15th of every month. Free. No paywall. No noise between issues.
Every space you inhabit is modulating your nervous system and reward system — they are intricately linked. The question is whether it was designed to.
The Practice
MOR Studio
Planning, architecture, and interiors designed around the nervous system and reward system — the two are intricately linked, and we design for both.
The Translation
My Dopamine Blueprint™
The receptor system, translated for the rest of us. Home of The MOR Code and the ongoing work on the mu-opioid receptor as the wellbeing receptor.